DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.compose your message
message sent
email sent successfully
Trusted Resources: News & Events
Latest announcements and gatherings
From Early Hypothesis to Clinical Data About Reducing Vaso-Occlusive Episodes with Arginine Therapy
At the 40th American Society of Hematology (ASH) Annual Meeting and Exposition investigators discussed an early hypothesis about Arginine (Arg) therapy as treatment for vaso-occlusive episdes (VOEs) in patients with sickle cell disease (SCD).
Almost 25 years later, Dr. Claudia Morris concluded 2022 by presenting phase 2 data at the 64th ASH Annual Meeting that demonstrated the therapy’s benefit, and her original premise. Her team’s phase 3 trial evaluating Arg is currently underway.
The primary outcome for the latest data was total parenteral opioid use in milligrams per kilo of IV morphine. Despite the unexpected interruptions of severe pain experienced by this patient population, treatments for acute pain related to sickle cell disease are lacking.
Related Content
-
education & researchA systematic review of the association between depression and health care utilization in children and adults with si...Patients with sickle cell disease (SCD) ...
-
education & researchImpact of Neuropathic Pain on Quality Of Life in Adults With Sickle Cell Disease: Observational StudyIntroduction: Knowledge on the characte...
-
people & placesAngela Rivers, MD, PhDDr. Rivers is the Director at Sickle Cel...
-
Community CenterToday’s Faces of Sickle Cell Disease: Wanda Whitten-Shurney, MDWanda Whitten-Shurney is a pediatrician,...
-
people & placesDonald Rucknagel, MD, PhDDr. Rucknagel pioneered the use of incen...
-
news & eventsVitamin D Supplements May Reduce Pain-related Emergency Room Visits in Children With SCDTaking vitamin D supplements may lower t...
-
videos & visualsWhat Should Teens Ask Their Doctors About Hydroxyureahttps://www.youtube.com/watch?v=VZn15uXQ...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.